CORRECTION: Ultralife Q2 EPS $0.15 Misses $0.19 Estimate, Sales $47.943M Miss $55.000M Estimate
Share
Why It Matters
Ultralife made less money than experts thought it would—both in profit per share and total sales. When a company misses these targets, it can mean they faced challenges or the market wasn't as strong as hoped, so it's worth watching how they explain what happened next.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.